Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)

BACKGROUND: Several dual bronchodilator combinations of long‐acting beta(2)‐agonist (LABA) and long‐acting muscarinic antagonist (LAMA) have been approved for treatment of stable chronic obstructive pulmonary disease (COPD). The current GOLD (Global Initiative for Chronic Obstructive Lung Disease) r...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cochrane Database Syst Rev
Main Authors: Ni, Han, Moe, Soe, Soe, Zay, Myint, Kay Thi, Viswanathan, K Neelakantan
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2018
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6517126/
https://ncbi.nlm.nih.gov/pubmed/30536566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011594.pub2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki